Humana faces significant challenges with rising denial rates and customer disenrollment, which have led to a sharp decline in stock value and profitability. Medicare Advantage's struggles, including ...
The healthcare sector is a haven to trade amid market volatility, with the Healthcare sector ETF down only 3.3% YTD compared to the S&P 500's 15% decline. Humana's stock has shown resilience, boosted ...
Zacks Investment Research on MSN
Humana partners with Atlas to enhance cancer care for seniors
Humana Inc. HUM recently unveiled a tie-up with Atlas Oncology Partners in a bid to provide enhanced cancer care, ...
In 2022, more Medicare Advantage plans will offer nonmedical supplemental benefits that address various social determinants of health such as meals, nutrition, transportation and in-home support ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results